Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 53.54

-3.1%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (2731)	1/30/2001 9:19:52 PM
From: Scott H. Davis	Read Replies (3) of 52153

The NBIX down move was prompted by a EPS downside surprise of 45%, with yearly loss much larger than estimates (tho the yearly est had to be a mistake since they had already lost more than that) not too bad considering the biotech index was also down. Rick, I actually do pay some attention to what stocks you & Miljenko post on favorably (plus others) picking up on REGN & NBIX at year end. Wish I'd been a little more patient, but then I've never billed myself as a market timer either. Going to do some homework & listen to the VICL CCall "from both sides now". Scott

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next